DCP Stock Overview
Engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Dis-Chem Pharmacies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R36.41 |
| 52 Week High | R40.00 |
| 52 Week Low | R27.20 |
| Beta | 0.19 |
| 1 Month Change | -1.97% |
| 3 Month Change | -1.67% |
| 1 Year Change | 24.22% |
| 3 Year Change | 4.24% |
| 5 Year Change | 37.60% |
| Change since IPO | 69.51% |
Recent News & Updates
Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?
Nov 27
Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value
Nov 10Recent updates
Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?
Nov 27Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value
Nov 10These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09Shareholder Returns
| DCP | ZA Consumer Retailing | ZA Market | |
|---|---|---|---|
| 7D | -1.4% | -2.9% | -2.9% |
| 1Y | 24.2% | 14.8% | 10.1% |
Return vs Industry: DCP exceeded the ZA Consumer Retailing industry which returned 14.8% over the past year.
Return vs Market: DCP exceeded the ZA Market which returned 10.1% over the past year.
Price Volatility
| DCP volatility | |
|---|---|
| DCP Average Weekly Movement | 3.0% |
| Consumer Retailing Industry Average Movement | 3.0% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in ZA Market | 8.8% |
| 10% least volatile stocks in ZA Market | 2.5% |
Stable Share Price: DCP has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: DCP's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | n/a | Rui Morais | dischemgroup.com |
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers a range of products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products.
Dis-Chem Pharmacies Limited Fundamentals Summary
| DCP fundamental statistics | |
|---|---|
| Market cap | R31.22b |
| Earnings (TTM) | R1.06b |
| Revenue (TTM) | R37.99b |
29.4x
P/E Ratio0.8x
P/S RatioIs DCP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DCP income statement (TTM) | |
|---|---|
| Revenue | R37.99b |
| Cost of Revenue | R29.38b |
| Gross Profit | R8.61b |
| Other Expenses | R7.55b |
| Earnings | R1.06b |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.24 |
| Gross Margin | 22.66% |
| Net Profit Margin | 2.79% |
| Debt/Equity Ratio | 47.9% |
How did DCP perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield40%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 06:50 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2024/02/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dis-Chem Pharmacies Limited is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Dias | Arqaam Capital Research Offshore S.A.L. |
| Michael de Nobrega | Avior Capital Markets |
| Paul Henri Steegers | BofA Global Research |